We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,407
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CASA
14076
PUT
DELISTED
Casa Systems, Inc. Common Stock
CASA
$85 ﹤0.01%
100
-800
-89% -$778
LLAP
14077
CALL
DELISTED
Terran Orbital Corporation
LLAP
$83 ﹤0.01%
+100
New +$132
SAMAW
14078
DELISTED
Schultze Special Purpose Acquisition Corp. II Warrant
SAMAW
$83 ﹤0.01%
16,526
+426
+3% +$17
WKEY
14079
PUT
WISeKey
WKEY
$79.7M
$74 ﹤0.01%
+40
New +$132
ENTX icon
14080
PUT
Entera Bio
ENTX
$140M
$73 ﹤0.01%
+100
New +$74
JSPR icon
14081
PUT
Jasper Therapeutics
JSPR
$27.4M
$70 ﹤0.01%
10
-30
-75% -$366
ISUN
14082
PUT
DELISTED
iSun, Inc. Common Stock
ISUN
$67 ﹤0.01%
300
– –
CBD
14083
PUT
DELISTED
Companhia Brasileira de Distribuicao
CBD
$67 ﹤0.01%
+100
New +$299
FBRX icon
14084
PUT
Forte Biosciences
FBRX
$1.57B
$66 ﹤0.01%
4
– –
MOBQW
14085
DELISTED
Mobiquity Technologies, Inc. Warrant
MOBQW
$63 ﹤0.01%
17,496
+2,221
+15% +$38
JUN.WS
14086
DELISTED
Juniper II Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
JUN.WS
$59 ﹤0.01%
+22,850
New +$1.17K
XXII
14087
22nd Century Group
XXII
$1.5M
– –
0
– –
YSG
14088
Yatsen Holding
YSG
$316M
$53 ﹤0.01%
11
-34
-76% -$182
BKYI
14089
CALL
BIO-key International
BKYI
$3.7M
$52 ﹤0.01%
1
-5
-83% -$568
SYRE icon
14090
PUT
Spyre Therapeutics
SYRE
$9.09B
$49 ﹤0.01%
+4
New +$53
HAYN
14091
DELISTED
Haynes International, Inc.
HAYN
$47 ﹤0.01%
1
-112
-99% -$5.46K
CREXW
14092
DELISTED
Creative Realities, Inc. Warrant
CREXW
$46 ﹤0.01%
17,186
-300
-2% -$2
AKA icon
14093
PUT
a.k.a. Brands
AKA
$115M
$43 ﹤0.01%
+8
New +$45
GORO icon
14094
PUT
Goldgroup Mining Inc.
GORO
$208M
$43 ﹤0.01%
+100
New +$53
ENSV
14095
PUT
DELISTED
Enservco Corp.
ENSV
$38 ﹤0.01%
+100
New +$37
LGHL
14096
CALL
Lion Group Holding
LGHL
$692K
– –
0
– –
DDL
14097
Dingdong
DDL
$529M
$33 ﹤0.01%
17
-54,009
-100% -$125K
IBIO icon
14098
PUT
iBio
IBIO
$70.5M
$30 ﹤0.01%
5
-5
-50% -$43
GLMD icon
14099
CALL
Galmed Pharmaceuticals
GLMD
$4.32M
$26 ﹤0.01%
+4
New +$53
TMC icon
14100
TMC The Metals Company
TMC
$1.7B
$26 ﹤0.01%
+26
New +$37
562 563
564
565 566

Similar funds

Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,407 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.